Celgene Corp. buy geldnutzer
Start price
24.12.15
/
50%
€109.54
Target price
11.01.16
€133.95
Performance (%)
-15.45%
End price
11.01.16
€92.62
Summary
This prediction ended on 11.01.16 with a price of €92.62. The price of Celgene Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.45%. geldnutzer has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | -1.665% | -10.870% | -0.717% | 41.869% |
| iShares Nasdaq 100 | -3.766% | -5.147% | 13.412% | 70.295% |
| iShares Nikkei 225® | -2.803% | -11.299% | 25.461% | 45.956% |
| iShares S&P 500 | -2.299% | -4.801% | 8.938% | 54.178% |
Comments by geldnutzer for this prediction
In the thread Celgene Corp. diskutieren
Auf zu Neuen Kursen
Diese Aktie gehört im Biotech-Sektor zu den Basis-Anlagen.
Hier wird es jetzt weiter nach oben gehen, 2016 kann kommen.
(Vom Mitglied beendet)